v-Abl protein tyrosine kinase (PTK) mediated suppression of apoptosis is associated with the up-regulation of Bcl-X-L

被引:23
作者
Chen, Q
Turner, J
Watson, AJM
Dive, C
机构
[1] UNIV MANCHESTER, SCH BIOL SCI, MOL PHARMACOL GRP, MANCHESTER M13 9PT, LANCS, ENGLAND
[2] UNIV MANCHESTER, DEPT MED, MANCHESTER M13 9PT, LANCS, ENGLAND
基金
英国医学研究理事会;
关键词
apoptosis; v-Abl tyrosine kinase; Bcl-X-L survival signals;
D O I
10.1038/sj.onc.1201371
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We demonstrated previously that the activation of v-Abl protein tyrosine kinase (PTK) in IC.DP murine pre-mast cells resulted in suppression of apoptosis after withdrawal of interleukin 3 (IL-3), that protein kinase C (PKC) translocated to the nucleus 6 h after v-Abl PTK activation and that inhibition of PKC restored apoptosis after IL-3 deprivation in the presence of v-Abl PTK activity. Here we demonstrate that v-Abl PTK activation is followed by an approximately twofold increase in mRNA level of Bcl-X-L by 6 h and a corresponding increase in Bcl-X-L protein level by 24 h. Bcl-x(L) RNA and protein decreased in IL-3 deprived cells in the absence of v-Abl PTK activity. Exposure of cells with v-Abl PTK active to the PKC inhbitor calphostin C (125 ng/ml) prevented the increase in Bcl-x(L) protein and resulted in apoptosis. No changes in Bax or Bcl-2 protein level were noted after IL-3 withdrawal and/or activation of v-Abl PTK. Bak was barely detectable and Bad protein level decreased in cells undergoing apoptosis. The data suggest that suppression of apoptosis by v-Abl PTK in the absence of IL-3 is associated with PKC signalling and the upregulation of Bcl-x(L) in IC.DP cells.
引用
收藏
页码:2249 / 2254
页数:6
相关论文
共 43 条
[31]  
OWEN PJ, 1993, J BIOL CHEM, V268, P15696
[32]   V-ABL-MEDIATED APOPTOTIC SUPPRESSION IS ASSOCIATED WITH SHC PHOSPHORYLATION WITHOUT CONCOMITANT MITOGEN-ACTIVATED PROTEIN-KINASE ACTIVATION [J].
OWENLYNCH, PJ ;
WONG, AKY ;
WHETTON, AD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (11) :5956-5962
[33]   SOCIAL CONTROLS ON CELL-SURVIVAL AND CELL-DEATH [J].
RAFF, MC .
NATURE, 1992, 356 (6368) :397-400
[34]  
Reed John C., 1995, Current Opinion in Oncology, V7, P541, DOI 10.1097/00001622-199511000-00012
[35]   HUMAN INTERLEUKIN-3 RECEPTOR MODULATES BCL-2 MESSENGER-RNA AND PROTEIN-LEVELS THROUGH PROTEIN-KINASE-C IN TF-1 CELLS [J].
RINAUDO, MS ;
SU, K ;
FALK, LA ;
HALDAR, S ;
MUFSON, RA .
BLOOD, 1995, 86 (01) :80-88
[36]   TUMORIGENIC ACTIVITY OF THE BCR-ABL ONCOGENES IS MEDIATED BY BCL2 [J].
SANCHEZGARCIA, I ;
GRUTZ, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (12) :5287-5291
[37]   THE NUCLEAR TYROSINE KINASE C-ABL NEGATIVELY REGULATES CELL-GROWTH [J].
SAWYERS, CL ;
MCLAUGHLIN, J ;
GOGA, A ;
HAVLIK, M ;
WITTE, O .
CELL, 1994, 77 (01) :121-131
[38]  
Shuai K, 1996, ONCOGENE, V13, P247
[39]   BCL-2 GENE PROMOTES HEMATOPOIETIC-CELL SURVIVAL AND COOPERATES WITH C-MYC TO IMMORTALIZE PRE-B-CELLS [J].
VAUX, DL ;
CORY, S ;
ADAMS, JM .
NATURE, 1988, 335 (6189) :440-442
[40]   CELLULAR RNA HOMOLOGOUS TO THE ABELSON MURINE LEUKEMIA-VIRUS TRANSFORMING GENE - EXPRESSION AND RELATIONSHIP TO THE VIRAL SEQUENCE [J].
WANG, JYJ ;
BALTIMORE, D .
MOLECULAR AND CELLULAR BIOLOGY, 1983, 3 (05) :773-779